Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine

The efficacy of hydroxychloroquine (HCQ) therapy, a previous candidate drug for coronavirus disease 2019 (COVID-19), was denied in the global guideline. The risk of severe cardiac events associated with HCQ was inconsistent in previous reports. In the present case series, we show the tolerability of...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tomohiro Tanaka, Masaki Okamoto, Norikazu Matsuo, Yoshiko Naitou-Nishida, Takashi Nouno, Takashi Kojima, Yuuya Nishii, Yoshihiro Uchiyashiki, Hiroaki Takeoka, Yoji Nagasaki
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-03-01
Schriftenreihe:	Medicina
Schlagworte:	coronavirus disease 2019 hydroxychloroquine severe acute respiratory syndrome
Online-Zugang:	https://www.mdpi.com/1648-9144/59/3/541
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!